Battlefield Auricular Acupressure (BAApress) Feasibility Study

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05939388
Collaborator
(none)
20
1
1
11
1.8

Study Details

Study Description

Brief Summary

The purpose of this research study is to find out what effects (good and bad) acupressure applied to the outside of the ear (Auricular Acupressure), in addition to the standard of care medication regimen, will have on pain. This study is being done to assess whether acupressure in addition to prescribed pain medication may be of benefit in decreasing pain levels and improving overall wellbeing. This study will also evaluate the feasibility of routinely offering acupressure to patients having pain issues in addition to a psychiatric diagnosis.

Condition or Disease Intervention/Treatment Phase
  • Device: Auricular Acupressure Pads
N/A

Detailed Description

The purpose of this study is to test the feasibility of Emergency Department nurse-initiated battlefield auricular acupressure as an adjunct to medication for pain management for psychiatric Emergency Department Observation patients.

The Battlefield Auricula Acupressure interventionists (nurse) will complete Auricular training modules and complete competency assessments and intervention assessments throughout the study. Study interventionist will include the possibility that a study participant may be part of a competency assessment and that their session may be recorded and securely uploaded to a server per IRB and institutional policies.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Battlefield Auricular Acupressure (BAApress) for Emergency Department Observation Psychiatric Patients With Co-occurring Chronic and Acute Pain Management
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Auricular Acupressure Pad Group

All subjects who qualify and agree to be in the study will be given Auricular Acupressure using an acupressure pad containing acupressure seeds for 4 days in addition to their regular standard of care pain medication.

Device: Auricular Acupressure Pads
Pads containing seeds that are placed on specific sites of the ear that are thought to help with pain.

Outcome Measures

Primary Outcome Measures

  1. Patient reported pain and general activity scores (Visual Analogue Scale) [Baseline]

    Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

  2. Patient reported pain and general activity scores (Visual Analogue Scale) [Day 1]

    Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

  3. Patient reported pain and general activity scores (Visual Analogue Scale) [Day 2]

    Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

  4. Patient reported pain and general activity scores (Visual Analogue Scale) [Day 3]

    Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Secondary Outcome Measures

  1. Pain Medication Usage [Baseline, Day 1, Day 2, Day 3]

    Average milligram per day sorted by medication name.

  2. General Anxiety Disorder Scale (GAD-7) [Baseline, Day 1, Day 2, Day 3]

    GAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

  3. Battlefield auricular acupressure (BAA) press Question 1 [Day 3]

    Three questions will be ask of evaluate acceptance of the intervention. Percent responding to the following question will be recorded: 1. "How satisfied were you with how your pain has been treated?" using the Likert scale to measure "Very satisfied =5, Satisfied=4, Somewhat satisfied = 3, Somewhat dissatisfied= 2, Dissatisfied 1, Very Dissatisfied 0." Range 0-5, will treat as ordinal data and provide descriptive statistics

  4. Battlefield auricular acupressure (BAA) press question 2 [Day 3]

    Three questions will be ask of evaluate acceptance of the intervention. Responses to the following will be analyzed quantitative an 2. Would you consider using auricular acupressure in the future for pain or if recommended by your nurse or physician? a. No, would not use again (Score of 0) b. Maybe (Score of 1), c. Yes, I would consider using in the future (Score of 2). Will analyze with descriptive stats with percent responding to each answer. 3. Is there anything else you would like to tell us that may be helpful for us to know regarding ear acupressure? (Each answer will be collected and assessed for future studies). Will collect qualitative data for later analysis for content.

  5. BAA Press placement survey (interventionists only) [Day 1]

    The Interventionist (Acupressure nurse) will be asked to capture time related to completion of study tasks and other qualitative questions to assess overall feasibility. Time recorded in minutes.

  6. Pain Management Satisfaction Score [Day 3]

    Would you consider using auricular acupressure in the future for pain or if recommended by your nurse or physician? a. No, would not use again (Score of 0) b. Maybe (Score of 1), c. Yes, I would consider using in the future (Score of 2). Higher score indicates more satisfaction.

Other Outcome Measures

  1. Brief Pain Inventory (BPI) [Baseline, Day 1, Day 2, Day 3]

    BPI is the Pain Interference Scale (7 items) and Pain Severity (4) items totaled and mean will be reported.

  2. Battlefield auricular acupressure (BAA) press question 3 [Day 3]

    Three questions will be ask of evaluate acceptance of the intervention. Responses to the following will be analyzed qualitatively: 2. Would you consider using auricular acupressure in the future for pain or if recommended by your nurse or physician? a. No, would not use again (Score of 0) b. Maybe (Score of 1), c. Yes, I would consider using in the future (Score of 2). Will analyze with descriptive stats with percent responding to each answer. 3. Is there anything else you would like to tell us that may be helpful for us to know regarding ear acupressure? (Each answer will be collected and assessed for future studies). Will collect qualitative data for later analysis for content.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients requiring admission to psychiatric emergency room who also have documented chronic or acute pain

  • History of chronic or acute pain with or without opioid use disorder

  • Expected length of stay at least 2-3 days at the time of recruitment

  • Able to read and understand the informed consent form

Exclusion Criteria:
  • Since this is a feasibility pilot, only English-speaking participants will be eligible.

  • Cognitive impairment (Intellectual Disability Disorder or Dementia)

  • Patients who have a legal guardian

  • Participants with a history of skin disease (e.g., psoriasis) involving the ear, adhesive allergy, recent scar tissue on ear, or current abrasions or cuts on ear,

  • Use of some types of hearing aids (obstructing the placement of beads)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Atrium Health Charlotte North Carolina United States 28105

Sponsors and Collaborators

  • Wake Forest University Health Sciences

Investigators

  • Principal Investigator: Michelle Olshan-Perlmutter, PMHCNS-BC, Wake Forest University Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT05939388
Other Study ID Numbers:
  • IRB00098172
First Posted:
Jul 11, 2023
Last Update Posted:
Jul 14, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Wake Forest University Health Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2023